Given that circulating CD45-CD90+CD44+ cells detected by flow cytometry were associated with early HCC recurrence, circulating cancer stem cell markers may have significant prognostic values in HCC [21]. This evidence concerns the gene THY1 and hepatocellular carcinoma.